Skip to main content

Lowey Dannenberg, P.C. is Investigating DaVita Inc. (NYSE: DVA) for Potential Violations of the Federal Securities Laws

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating DaVita Inc. (NYSE: DVA) (“DaVita” or the “Company”) for potential violations of the federal securities laws.

On October 20, 2026, the U.S. Department of Health and Human Services (“HHS”) announced “a coordinated department-wide strategy focused on revitalizing American kidney care.” The federal plan targets the concentrated structure of the domestic dialysis market, in which DaVita is a dominant provider, by introducing new competition measures, penalizing entrenched market dominance, and shifting incentives toward early-stage preventive care. The investigation concerns whether DaVita and its officers and/or directors made false and/or misleading statements and/or failed to disclose the Company’s exposure to regulatory and competitive risks arising from its market position, and whether the Company had a reasonable basis for its positive statements about its business, financial condition, and prospects.

Following this news, the price of DaVita stock fell $11.65 per share, or approximately 6.23%, from a close of $187.00 per share on October 19, 2026 to close at $175.35 per share on October 20, 2026, causing losses to shareholders.

“Our investigation concerns whether the company and its executives provided investors with accurate and complete information about the company,” said attorney Andrea Farah, Lowey Dannenberg, P.C. partner and head of the firm’s securities practice.

If you suffered a loss in DaVita securities, and wish to participate, or learn more about your eligibility, contact our attorneys Andrea Farah (afarah@lowey.com) at (914) 733-7256 or Vincent R. Cappucci Jr. (vcappucci@lowey.com) at (914) 733-7278.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

Contact

Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Tel: (914) 733-7256
Email: investigations@lowey.com

SOURCE: Lowey Dannenberg


Primary Logo

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  266.93
+7.63 (2.94%)
AAPL  350.69
+8.32 (2.43%)
AMD  508.58
+59.54 (13.26%)
BAC  50.55
+1.13 (2.29%)
GOOG  286.01
+2.08 (0.73%)
META  641.37
+31.22 (5.12%)
MSFT  545.18
+14.57 (2.75%)
NVDA  178.67
-7.97 (-4.27%)
ORCL  119.79
+3.69 (3.18%)
TSLA  378.05
+19.83 (5.54%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.